Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis

Overview of attention for article published in Frontiers in Pharmacology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Readers on

mendeley: 1 Mendeley

Summary X Facebook

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,072 followers.

RT @FrontPharmacol: New Research: Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the tre…

08 Feb 2024

Reply Repost Favourite

New Research: Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis https://t.co/eCB4qmlOPx #pharmacology

07 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.